Eunomia helps pharmaceutical and biotech teams develop and operationalise fair market value (FMV) frameworks for healthcare professional engagements. Our UK FMV consulting support connects compensation methodology, documented expertise, engagement scope and approval records with the way your teams contract and pay for services.
Discuss this service
UK expertise · Practical delivery
Compliance, Medical Affairs, Legal, Finance and operational teams in emerging biotech and established pharmaceutical companies. Support can be scoped for a UK engagement model or a multi-market framework with country-specific inputs.
Different spreadsheets, inconsistent tiering and undocumented exceptions can leave teams unable to reconstruct why a fee was selected. A rate card alone does not explain the service, the time commitment or the evidence behind a decision.
From requirements to action
Depending on the agreed scope, deliverables can include:
FMV projects typically take one to three months, depending on the number of countries covered. We agree the scope, required inputs and delivery timeline before work begins. Our focus is HCP compensation and engagement frameworks; we do not provide clinical-trial budget or pricing assessments.
Start with the countries, stakeholder groups and engagement types you need to cover, your existing methodology and rate cards, and any known concerns. Benchmark availability and licensing are confirmed during scoping.
Discuss your requirementsWhat we can take on
What this gives you
A traceable explanation of compensation decisions
Consistent assessment and escalation across teams
An FMV framework connected to everyday engagement workflows
The rules in the UK
Confirm the applicable code and market scope before using an FMV process. The following UK reference informs the engagement review. Each summary links to its official source below.
For arrangements within its scope, Clause 24.2 connects documented need and selection, advance written agreement, appropriate records and reasonable remuneration reflecting fair market value. It also addresses the risk of using an engagement as an inducement.
Related project
Fair Market Value Methodology for HCP Compensation. Read the published project account for an example of methodology, tiering and rate-card work. The case study is not a public rate schedule or a guarantee of future results.
More reading: HCP FMV assessment guide and worksheet · FMV methodology case study
This overview is informational and does not constitute legal advice. Scope and application should be confirmed for the organisation, activity and counterparty in question. Sources checked September 2026.
Questions, answered
The scope can include methodology, source-data review, documented tiering, rate-card governance and engagement-level assessment. We agree the countries, stakeholder groups, activities and deliverables before work begins.
This service does not provide a universal rate. An assessment needs a documented methodology and relevant evidence for the specific services and market. The accompanying worksheet records the rationale and approvals; it does not calculate or certify an FMV rate.
Yes. We can review the methodology, evidence, tiering approach, exceptions and operating process, then agree priorities for updating and implementing the framework.
No. Compensation is one part of an engagement decision. The applicable requirements, business need, selection, contracting and other controls still need their own review.
Defined steps such as collecting evidence, routing approvals, recording exceptions and reporting can be supported through controlled workflows. Accountable reviewers retain the decisions and approved methodology.
Eunomia’s FMV projects typically take one to three months, depending on the number of countries covered. We agree the scope, required inputs and delivery timeline before work begins.
No. Our FMV services focus on HCP compensation and engagement frameworks. We do not provide clinical-trial budget or pricing assessments.
Bring your current methodology, engagement types, countries, rate cards and known concerns. We agree a focused review or a wider framework project. Share confidential records only through an agreed secure channel.
We will listen, ask a few questions and recommend the right scope—without obligation or pressure.
Start a conversation